Kim BR - Search Results

1

Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2.

Rho SB, Song YJ, Lim MC, Lee SH, Kim BR, Park SY. Rho SB, et al. Among authors: kim br. Cell Signal. 2012 Jan;24(1):131-9. doi: 10.1016/j.cellsig.2011.08.013. Epub 2011 Aug 26. Cell Signal. 2012. PMID: 21893193

2

A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3'-kinase (PI3K)/AKT pathway in ovarian cancer cells.

Rho SB, Kim BR, Kang S. Rho SB, et al. Among authors: kim br. Gynecol Oncol. 2011 Jan;120(1):121-7. doi: 10.1016/j.ygyno.2010.10.003. Epub 2010 Oct 29. Gynecol Oncol. 2011. PMID: 21035837

3

PDCD6 additively cooperates with anti-cancer drugs through activation of NF-κB pathways.

Park SH, Lee JH, Lee GB, Byun HJ, Kim BR, Park CY, Kim HB, Rho SB. Park SH, et al. Among authors: kim br, kim hb. Cell Signal. 2012 Mar;24(3):726-33. doi: 10.1016/j.cellsig.2011.11.006. Epub 2011 Nov 12. Cell Signal. 2012. PMID: 22142513

4

Tumor suppressor BLU enhances pro-apoptotic activity of sMEK1 through physical interaction.

Dong SM, Byun HJ, Kim BR, Lee SH, Trink B, Rho SB. Dong SM, et al. Among authors: kim br. Cell Signal. 2012 Jun;24(6):1208-14. doi: 10.1016/j.cellsig.2012.02.002. Epub 2012 Feb 12. Cell Signal. 2012. PMID: 22349239

5

Dickkopf-1 (DKK-1) interrupts FAK/PI3K/mTOR pathway by interaction of carbonic anhydrase IX (CA9) in tumorigenesis.

Kim BR, Shin HJ, Kim JY, Byun HJ, Lee JH, Sung YK, Rho SB. Kim BR, et al. Among authors: kim jy. Cell Signal. 2012 Jul;24(7):1406-13. doi: 10.1016/j.cellsig.2012.03.002. Epub 2012 Mar 10. Cell Signal. 2012. PMID: 22430125

6

Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.

Kang S, Dong SM, Kim BR, Park MS, Trink B, Byun HJ, Rho SB. Kang S, et al. Among authors: kim br. Apoptosis. 2012 Sep;17(9):989-97. doi: 10.1007/s10495-012-0717-2. Apoptosis. 2012. PMID: 22460505 Free PMC article.

7

DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis.

Yoo HJ, Byun HJ, Kim BR, Lee KH, Park SY, Rho SB. Yoo HJ, et al. Among authors: kim br. Cell Signal. 2012 Jul;24(7):1471-7. doi: 10.1016/j.cellsig.2012.03.010. Epub 2012 Mar 23. Cell Signal. 2012. PMID: 22465880

8

sMEK1 enhances gemcitabine anti-cancer activity through inhibition of phosphorylation of Akt/mTOR.

Byun HJ, Kim BR, Yoo R, Park SY, Rho SB. Byun HJ, et al. Among authors: kim br. Apoptosis. 2012 Oct;17(10):1095-103. doi: 10.1007/s10495-012-0751-0. Apoptosis. 2012. PMID: 22903553

9

Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway.

Byun HJ, Lee JH, Kim BR, Kang S, Dong SM, Park MS, Lee SH, Park SH, Rho SB. Byun HJ, et al. Among authors: kim br. Microvasc Res. 2012 Nov;84(3):227-34. doi: 10.1016/j.mvr.2012.09.006. Epub 2012 Sep 26. Microvasc Res. 2012. PMID: 23022044

10

GABAA receptor-binding protein promotes sensitivity to apoptosis induced by chemotherapeutic agents.

Rho SB, Byun HJ, Kim BR, Kim IS, Lee JH, Yoo R, Park ST, Park SH. Rho SB, et al. Among authors: kim br, kim is. Int J Oncol. 2013 May;42(5):1807-14. doi: 10.3892/ijo.2013.1866. Epub 2013 Mar 27. Int J Oncol. 2013. PMID: 23545901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

798 results

Search Page

Filters